Sign in

CIK 0002044725

  • Emerging growth company

Evommune, Inc.

Sign in to watch
Ticker
EVMN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850742575
Phone
+1 650-223-7745
Business address
1891 PAGE MILL RD, PALO ALTO, CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-05 Moss Gregory S. Chief Business & Legal Officer Grant or award · Employee Stock Option (Right to Buy) +293,496 293,496
2025-11-05 Pena Luis C. President & CEO Grant or award · Employee Stock Option (Right to Buy) +796,841 796,841
2025-11-05 Cohen David E Director Grant or award · Stock Option (Right to Buy) +37,960 37,960
2025-11-05 KIRSCH ARTHUR S Director Grant or award · Stock Option (Right to Buy) +37,960 37,960
2025-11-05 MCGRAW BENJAMIN F III Director Grant or award · Stock Option (Right to Buy) +37,960 37,960

Page 8 of 8 · 145 trades